• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

FDA gives go-ahead to foldable acrylic IOL

Article

The FDA has approved Advanced Medical Optics’ (AMO) Tecnis IOL on an acrylic platform. AMO said it plans to release the Tecnis foldable acrylic IOL commercially in the United States and Europe this month.

The FDA has approved Advanced Medical Optics’ (AMO) Tecnis IOL on an acrylic platform. AMO said it plans to release the Tecnis foldable acrylic IOL commercially in the United States and Europe this month.

The company said the IOL has the same unique benefits as its Tecnis silicone IOL and added that the Tecnis lens reduces spherical aberration and improves functional vision in varying light conditions.

In a simulated night-driving study, patients viewing a rural road through a Tecnis lens identified a pedestrian hazard significantly sooner than through a traditional spherical IOL. The company’s lens also provided a 45-foot advantage in detection and identification distance, according to AMO.

Related Videos
Paul Badawi, co-founder and CEO of Sight Sciences, chats with Neda Shamie, MD, about what drives him
© 2024 MJH Life Sciences

All rights reserved.